Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: https://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2025, 13(9), 345-355
DOI: 10.12691/jfnr-13-9-2
Open AccessArticle

Anti-cancer Effect of the Ethyl Acetate Fraction from Opuntia humifusa on A-549 Human Lung Cancer Cells

Eon Ji Yeo1, Myung Chul Cha2 and Dong Seok Lee1, 3,

1Department of Smart Food and Drug, Graduate School, Inje University, Gimhae 50834, Republic of Korea

2Institue of Digital Anti-aging Healthcare, Graduate School, Inje University, Gimhae 50834, Republic of Korea

3Institue of Digital Anti-aging Healthcare, Graduate School, Inje University, Gimhae 50834, Republic of Korea;Department of Biomedical Laboratory Science, Inje University, 197 Inje-ro, Gimhae 50834, Gyeongsangnam-do, Republic of Korea

Pub. Date: September 17, 2025

Cite this paper:
Eon Ji Yeo, Myung Chul Cha and Dong Seok Lee. Anti-cancer Effect of the Ethyl Acetate Fraction from Opuntia humifusa on A-549 Human Lung Cancer Cells. Journal of Food and Nutrition Research. 2025; 13(9):345-355. doi: 10.12691/jfnr-13-9-2

Abstract

The anti-cancer effects of the ethyl acetate (EtOAc) fraction (E-OHS) from the ethanol extract of Opuntia humifusa against A-549 human lung cancer cells were investigated. Selective cytotoxicity was assessed in RAW 264.7 cells and A-549 cells using the MTS assay. After Annexin V-FITC/PI staining, apoptosis induction was confirmed by flow cytometry, and apoptotic nuclear fragmentation was examined using DAPI staining. Furthermore, induction of cell cycle arrest was confirmed by flow cytometry after PI staining, and anti-metastasis was evaluated using wound healing assay. The molecular mechanisms underlying apoptosis, cell cycle arrest, anti-metastasis, and upstream signaling were elucidated using western blot. E-OHS induced anti-cancer activity in a dose-dependent manner in A-549 cells, whereas it did not exhibit cytotoxicity in RAW 264.7 cells. Annexin V-FITC/PI and DAPI assays showed that number of apoptotic bodies increased in a dose-dependent manner. Western blot analysis showed that pro-caspase-9, pro-caspase-3, and PARP decreased, whereas cleaved-caspase-12, Bax, and cleaved PARP increased. This suggests that apoptosis was jointly induced through mitochondrial-mediated intrinsic pathway and endoplasmic reticulum (ER) stress-related pathway. Flow cytometry analysis showed that the distribution of G1/S phase cells increased in the E-OHS-treated group, whereas the distribution of G2/M phase cells decreased, confirming that E-OHS induced cell cycle arrest by inhibiting transition of G1/S phase. Western blot analysis reconfirmed at the molecular level that the cell cycle was arrested in the G1/S phase, as supported by the decrease in CDK2, CDK4, and cyclin A2. Wound-healing assay showed that the migration ability of A-549 cells was inhibited with E-OHS, and western blot analysis confirmed the decrease in integrin β1, MMP-9, and HIF-1α, demonstrating that E-OHS inhibits A-549 cell metastasis. Finally, western blot analysis showed a dose-dependent decrease in ERK1/2, confirming that induction of apoptosis and cell cycle arrest, as well as anti-metastasis, are influenced by upstream signaling pathway.

Keywords:
anti-cancer ethyl acetate fraction apoptosis cell cycle arrest anti-metastasis Opuntia humifusa

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Zhou, J., Xu, Y., Liu, J., Feng, L., Yu, J., & Chen, D., "Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN," Cancer Epidemiology93 102693, 2024.
 
[2]  Jung, H. A., Lee, D. H., Lim, S. M., Yu, H., Yoon, S., Kim, D., ...& Toh, K. C., "Epidemiology and outcomes of non–small cell lung cancer in South Korea," JAMA Network Open 7(2), e2355331-e2355331, 2024.
 
[3]  Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A., "Cancer statistics, 2025," CA: A Cancer Journal for Clinicians 75(1), 10-45, 2025.
 
[4]  Zheng, M., "Classification and pathology of lung cancer," Surgical Oncology Clinics 25(3), 447-468, 2016.
 
[5]  Ambrosini, V., Nicolini, S., Caroli, P., Nanni, C., Massaro, A., Marzola, M. C., R. Domenico& Fanti, S., “PET/CT imaging in different types of lung cancer: an overview,” European Journal of Radiology 81(5), 988-1001, 2012.
 
[6]  Baldelli, E., El Gazzah, E., Moran, J. C., Hodge, K. A., Manojlovic, Z., Bassiouni, R., J. D. Carten, V. Ludovini, B. Sara, C. Lucio. B. Fortunato, T. Dong, L. Jeremy, P. F, Emanuel& Pierobon, M., “Wild-type KRAS allele effects on druggable targets in KRAS mutant lung adenocarcinomas,” Genes 12(9), 1402, 2021.
 
[7]  Jung, B. M., Shin, M. O., & Kim, H. R., "The effects of antimicrobial, antioxidant, and anticancer properties of Opuntiahumifusa stems," Journal of the Korean Society of Food Science and Nutrition 41(1) 20-25, 2012.
 
[8]  Park, C. M., Kwak, B. H., Sharma, B. R., & Rhyu, D. Y., "Anti-diabetic effect of Opuntia humifusa stem extract," Korean Journal of Pharmacognosy 43(4), 308-315, 2012.
 
[9]  Sharma, B. R., Park, C. M., Choi, J. W., & Rhyu, D. Y., "Anti-nociceptive and anti-inflammatory effects of the methanolic extract of Opuntia humifusa stem," Avicenna Journal of Phytomedicine 7(4), 366, 2017.
 
[10]  Lee, K. S., Kim, M. G., & Lee, K. Y., "Antimicrobial effect of the extracts of cactus Chounnyouncho (Opuntia humifusa) against food borne pathogens," Journal of the Korean Society of Food Science and Nutrition 33(8), 1268-1272, 2004.
 
[11]  Lee, J. N., Kim, H. E., & Kim, Y. S., "Anti-diabetic and anti-oxidative effects of Opuntia humifusa cladodes." Journal of the Korean Society of Food Science and Nutrition 43(5), 661-667, 2014.
 
[12]  Lagu, I. J. L., Nyamai, D. W., & Njeru, S. N., "Phytochemical analysis, In Vitroand in-silico study of antiproliferative activity of ethyl acetate fraction of Launaea cornuta (Hochst. ex Oliv. & Hiern) C. Jeffrey against human cervical cancer cell line," Frontiers in Pharmacology 15, 1399885, 2024.
 
[13]  Chao, W. W., Liou, Y. J., Ma, H. T., Chen, Y. H., & Chou, S. T., "Phytochemical composition and bioactive effects of ethyl acetate fraction extract (EAFE) of Glechoma hederacea L.," Journal of Food Biochemistry 45(7), e13815, 2021.
 
[14]  Riss, T. L., Moravec, R. A., Niles, A. L., Duellman, S., Benink, H. A., Worzella, T. J., & Minor. L., "Cell viability assays," Assay Guidance Manual [Internet], 2016.
 
[15]  Wang, P., Henning, S. M., & Heber, D., "Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols," PLOS One 5(4), e10202, 2010.
 
[16]  Crowley, L. C., & Waterhouse, N. J., "Detecting cleaved caspase-3 in apoptotic cells by flow cytometry," Cold Spring Harbor Protocols 2016 (11), pdb-prot087312, 2016.
 
[17]  Koopman, G., Reutelingsperger, C. P., Kuijten, G. A., Keehnen, R. M., Pals, S. T., & Van Oers, M. H., "Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis," Blood 84 (5),1415-1420, 1994.
 
[18]  Lakshmanan, I., & Batra, S. K., "Protocol for apoptosis assay by flow cytometry using annexin V staining method," Bio-protocol 3 (6), e374-e374, 2013.
 
[19]  Otto, F., "DAPI staining of fixed cells for high-resolution flow cytometry of nuclear DNA," Methods in Cell Biology. Vol. 33. Academic Press, 105-110, 1990.
 
[20]  Grada, A., Otero-Vinas, M., Prieto-Castrillo, F., Obagi, Z., & Falanga, V., "Research techniques made simple: analysis of collective cell migration using the wound healing assay," Journal of Investigative Dermatology 137(2) e11-e16, 2017.
 
[21]  Vayanaperumal, K., & Vayanaperumal, K., "Western Blotting a review: Principle, protocol and problem solving," GSC Advanced Research and Reviews 16 (3), 178-187, 2023.
 
[22]  Cha, M. C., & Lee, D. S., “Anti-cancer activities of the ethyl acetate fraction from Opuntia humifusa in PANC-1 human pancreatic cancer cells,” Journal of Food and Nutrition Research 11(9), 587-593, 2023.
 
[23]  Cha, M. N., Jun, H. I., Lee, W. J., Kim, M. J., Kim, M. K., & Kim, Y. S., “Chemical composition and antioxidant activity of Korean cactus (Opuntia humifusa) fruit,” Food Science and Biotechnology 22(2), 523-529, 2013.
 
[24]  Lee, K. S., Kim, M. G., & Lee, K. Y., “Antimicrobial effect of the extracts of cactus Chounnyouncho (Opuntia humifusa) against food borne pathogens,” Journal of the Korean Society of Food Science and Nutrition 33(8), 1268-1272, 2004.
 
[25]  Jung, B. M., Shin, M. O., & Kim, H. R., “The effects of antimicrobial, antioxidant, and anticancer properties of Opuntia humifusa stems,” Journal of the Korean Society of Food Science and Nutrition 41(1), 20-25, 2012.
 
[26]  Chennimalai, M., Vijayalakshmi, V., Senthil, T. S., & Sivakumar, N., “One-step green synthesis of ZnO nanoparticles using Opuntia humifusa fruit extract and their antibacterial activities,” Materials Today: Proceedings 47, 1842-1846, 2012.
 
[27]  Yanamala, P., Youn, J. Y., Thangavel, P., Moon, J. Y., & Lee, Y. C., “Evaluation of the antioxidant and anti-cancer potential of microwave-assisted Opuntia humifusa (Korean Cheonnyencho) aqueous extract,” Current Issues in Molecular Biology 47(2), 88, 2025.
 
[28]  Lee, J. N., Kim, H. E., & Kim, Y. S., “Anti-diabetic and anti-oxidative effects of Opuntia humifusa cladodes,” Journal of the Korean Society of Food Science and Nutrition, 43(5), 661-667, 2014.
 
[29]  Tronina, T., Bartmańska, A., Popłoński, J., Rychlicka, M., Sordon, S., Filip-Psurska, B., M. Magdalena & Huszcza, E., “Prenylated flavonoids with selective toxicity against human cancers,” International Journal of Molecular Sciences 24(8), 7408, 2023.
 
[30]  Yadav, A., Mandal, M. K., & Dubey, K. K., "In Vitro cytotoxicity study of cyclophosphamide, etoposide and paclitaxel on monocyte macrophage cell line RAW 264.7," Indian Journal of Microbiology60 (4), 511-517, 2020.
 
[31]  Jiang, S., Wang, R., Han, L., Kuerban, K., Ye, L., Pan, S., & Yuan, Y., “Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW 264. 7 macrophages by promoting TNF-α, IL-6 and MHC-II expression,” Immunologic Research 69(4), 352-362, 2021.
 
[32]  Du, X., Cui, X., Sun, X., Li, H., Xu, K., & Fu, X., “Platycodin D-Induced Immunotoxicity in RAW 264.7 macrophages via oxidative stress-mediated apoptosis,” Natural Product Communications 18(2), 1934578X221150366, 2023.
 
[33]  Green, D. R., “Apoptotic pathways: paper wraps stone blunts scissors,” Cell 102(1), 1-4, 2000.
 
[34]  Porter, A. G., & Jänicke, R. U., “Emerging roles of caspase-3 in apoptosis,” Cell Death & Differentiation 6(2), 99-104, 1999.
 
[35]  Hitomi, J., Katayama, T., Eguchi, Y., Kudo, T., Taniguchi, M., Koyama, Y.,T. Manabe, S. Yamagishi, Y. Bando, K. Imaizumi, & Tohyama, M., “Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death,” The Journal of Cell Biology 165 (3), 347-356, 2004.
 
[36]  Gross, A., McDonnell, J. M., & Korsmeyer, S. J., “BCL-2 family members and the mitochondria in apoptosis,” Genes &Development 13 (15), 1899-1911, 1999.
 
[37]  Antonsson, B., “Bax and other pro-apoptotic Bcl-2 family" killer-proteins" and their victim the mitochondrion,” Cell and Tissue Research 306 (3), 347-361, 2001.
 
[38]  Li, P., Zhou, L., Zhao, T., Liu, X., Zhang, P., Liu, Y., P. Zhang, Y. Liu, X. Zheng, & Li, Q., “Caspase-9: structure, mechanisms and clinical application,” Oncotarget 8 (14), 23996-24008, 2017.
 
[39]  Porter, A. G., & Jänicke, R. U., “Emerging roles of caspase-3 in apoptosis,” Cell Death & Differentiation 6 (2), 99-104, 1999.
 
[40]  Kim, C., Wang, X. D., Jang, S., & Yu, Y., “PARP1 inhibitors induce pyroptosis via caspase 3-mediated gasdermin E cleavage,” Biochemical and Biophysical Research Communications646, 78-85, 2023.
 
[41]  Lefebvre, J., Muharram, G., Leroy, C., Kherrouche, Z., Montagne, R., Ichim, G., S Tauszig, D, A Chotteau, L,Tulasne, D., “Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity,” Cell Death &Disease 4 (10), e871-e871, 2013.
 
[42]  Moldovan, C., Onaciu, A., Toma, V., Munteanu, R. A., Gulei, D., Moldovan, A., Stiufiuc, C., Feder, R, Cenariu, D., Luga, C., & Stiufiuc, R. I., “Current trends in luminescence-based assessment of apoptosis,” RSC Advances 13 (45), 31641-31658, 2023.
 
[43]  Boulares, A. H., Zoltoski, A. J., Contreras, F. J., Yakovlev, A. G., Yoshihara, K., & Smulson, M. E., “Regulation of DNAS1L3 endonuclease activity by poly (ADP-ribosyl) ation during etoposide-induced apoptosis: role of poly (ADP-ribose) polymerase-1 cleavage in endonuclease activation,” Journal of Biological Chemistry 277 (1), 372-378, 2002.
 
[44]  Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J., “Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β,” Nature 403 (6765), 98-103, 2000.
 
[45]  Hitomi, J., Katayama, T., Taniguchi, M., Honda, A., Imaizumi, K., & Tohyama, M., “Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12,” Neuroscience Letters357 (2), 127-130, 2004.
 
[46]  Li, H. L., Li, S. M., Luo, Y. H., Xu, W. T., Zhang, Y., Zhang, T., Dong-jie. Z., & Jin, C. H., “Kaempferide induces G0/G1 phase arrest and apoptosis via ROS-mediated signaling pathways in A549 human lung cancer cells,” Natural Product Communications 15 (7), 1934578X20935226, 2020.
 
[47]  Wang, R., Zhang, Q., Peng, X., Zhou, C., Zhong, Y., Chen, X., ... & Kong, D., “Stellettin B induces G1 arrest, apoptosis and autophagy in human non-small cell lung cancer A549 cells via blocking PI3K/Akt/mTOR pathway,” Scientific Reports 6 (1), 27071, 2016.
 
[48]  Guo, M., Liu, Z., Si, J., Zhang, J., Zhao, J., Guo, Z., Xie, Y., Zhang, H., & Gan, L., “Cediranib Induces Apoptosis, G1 Phase Cell Cycle Arrest, and Autophagy in Non‐Small‐Cell Lung Cancer Cell A549 In Vitro,” BioMed Research International 2021 (1), 5582648, 2021.
 
[49]  Tiwari, S., Roel, C., Wills, R., Casinelli, G., Tanwir, M., Takane, K. K., & Fiaschi-Taesch, N. M., “Early and late G1/S cyclins and Cdks act complementarily to enhance authentic human β-cell proliferation and expansion,” Diabetes 64 (10), 3485-3498, 2015.
 
[50]  Kwon, J. H., Lee, D. S., Jung, E. C., Kim, H. M., Kim, S. B., & Ryu, D. S., “Anti-cancer activity of the ethyl acetate fraction from Orostachys japonicus in A549 human lung cancer cells by induction of apoptosis and cell cycle arrest,” Asia-pacific Journal of Multimedia Services Convergent with Art, Humanities, and Sociology 7(1), 395-405, 2017.
 
[51]  Bian, X., Yin, S., Yin, X., Fang, T., Wang, Y., Yang, S., Xinju, J., Yingwei, X., Fei, Y., & Zhang, L., “Clinical and biological significances of FBLN5 in gastric cancer,” Cancers 15 (2), 553, 2023.
 
[52]  Wei, Pengxu, "Ultra-early screening of cognitive decline due to Alzheimer’s pathology," Biomedicines 11(5), 1423, 2023.
 
[53]  Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Eero, M., Lauri, E., Jonhanna I., & Saharinen, P., “Targeting β1-integrin inhibits vascular leakage in endotoxemia,” Proceedings of the National Academy of Sciences 115(28), E6467-E6476, 2018.
 
[54]  Xu, Z., Zou, L., Ma, G., Wu, X., Huang, F., Feng, T., Suqing, L., Qingfeng, L., Xiaoting, H., Zhihua, L., & Cao, X., “Integrin β1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma,” American Journal of Cancer Research 7(3), 531, 2017.
 
[55]  Luo, Y., Liang, F., & Zhang, Z. Y., “PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways,” Biochemistry 48(8), 1838-1846, 2009.
 
[56]  Sun, H. W., Li, C. J., Chen, H. Q., Lin, H. L., Lv, H. X., Zhang, Y., & Zhang, M., “Involvement of integrins, MAPK, and NF-κB in regulation of the shear stress-induced MMP-9 expression in endothelial cells,” Biochemical and Biophysical Research Communications353(1), 152-158, 2007.
 
[57]  Lee, C. J., Lee, M. H., Yoo, S. M., Choi, K. I., Song, J. H., Jang, J. H., Oh, S, R., Ryu, H, W., Lee, H, S,. Surh, Y, J., & Cho, Y. Y., "Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway," BMC Cancer 15(1), 576, 2015.
 
[58]  Luo, Y., Liang, F., & Zhang, Z. Y., “PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways,” Biochemistry 48(8), 1838-1846, 2009.
 
[59]  Ali, E. S., Akter, S., Ramproshad, S., Mondal, B., Riaz, T. A., Islam, M. T., Khan, I, N., Docea, A, O., Calina, D., Javad, S, F., & Cho, W. C., “Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview,” Cancer Cell International 22(1), 246, 2022.